Yue Feng

No ORCID on file · 5 papers in corpus
observational 2026
BMC endocrine disorders ·doi:10.1186/s12902-026-02177-2

BACKGROUND: This study utilizes data from two principal sources: the National Health and Nutrition Examination Survey (NHANES) conducted in the United States from 1999 to 2020 and the China Health and Retirement Longitudinal Study (CHARLS) …

review 2024
Cancer Immunology, Immunotherapy ·doi:10.1007/s00262-024-03708-3

Ovarian cancer is one of the most lethal malignant tumors, characterized by high incidence and poor prognosis. Patients relapse occurred in 65-80% after initial treatment. To date, no effective treatment has been established for these patie…

other 2023
Nuclear medicine communications ·doi:10.1097/mnm.0000000000001653

BACKGROUND: Currently, fluorine-18-fluorodeoxyglucose ( 18 F-FDG) is the most frequently used diagnostical radiotracer for PET/computed tomography (PET/CT) in ovarian malignancies. However, 18 F-FDG has some limitations. The fibroblast acti…

lab-animal 2022
Cell & bioscience ·doi:10.1186/s13578-022-00852-0

BACKGROUND: More than 70% of leiomyomas (LM) harbor MED12 mutations, primarily in exon 2 at c.130-131(GG). The cause of MED12 mutations in myometrial cells remains largely unknown. We hypothesized that increased ROS promotes MED12 mutations…

lab-animal 2010
Molecular Endocrinology ·doi:10.1210/me.2009-0155

Vascular endothelial growth factor (VEGF) and endometrial angiogenesis play a critical role in successful embryonic implantation. Despite many studies of the effects of estrogen and progesterone on VEGF expression, its focal regulation at t…